Utah Code § 26B-4-243
Guidance for treatment with medical cannabis
Utah · Utah Code Title 26B — Utah Health and Human Services Code · Status: effective
Cite this
- Citation
- Utah Code § 26B-4-243, Guidance for treatment with medical cannabis, Utah, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2332269
- Permanent ID
ys:prov:2332269@1- SHA-256
edaea6d1f6a029ff8851775e175ee28ebf28e84f169fa8b92a884c73f9a08fbe
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
The department, in consultation with the Center for Medical Cannabis Research created in Section 53H-4-206, shall:
(1) develop evidence-based guidance for treatment with medical cannabis based on the latest medical research that shall include:
(a) for each qualifying condition, a summary of the latest medical research regarding the treatment of the qualifying condition with medical cannabis;
(b) risks, contraindications, side effects, and adverse reactions that are associated with medical cannabis use; and
(c) potential drug interactions between medical cannabis and medications that have been approved by the United States Food and Drug Administration;
(2) educate recommending medical providers, pharmacy medical providers, medical cannabis cardholders, and the public regarding:
(a) the evidence-based guidance for treatment with medical cannabis described in Subsection (1)(a);
(b) relevant warnings and safety information related to medical cannabis use; and
(c) other topics related to medical cannabis use as determined by the department; and
(3) develop patient product information inserts for medical cannabis products:
(a) in consultation with the cannabis processing facility that created the product; and
(b) that do not contain proprietary information about the product.